BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25042059)

  • 1. Estimating heritability of drug-induced liver injury from common variants and implications for future study designs.
    Overby CL; Hripcsak G; Shen Y
    Sci Rep; 2014 Jul; 4():5762. PubMed ID: 25042059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-Clavulanate.
    Nicoletti P; Dellinger A; Li YJ; Barnhart HX; Chalasani N; Fontana RJ; Odin JA; Serrano J; Stolz A; Etheridge AS; Innocenti F; Govaere O; Grove JI; Stephens C; Aithal GP; Andrade RJ; Bjornsson ES; Daly AK; Lucena MI; Watkins PB; ; ;
    Gastroenterology; 2023 Mar; 164(3):454-466. PubMed ID: 36496055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human leucocyte antigen class II genotype in susceptibility and resistance to co-amoxiclav-induced liver injury.
    Donaldson PT; Daly AK; Henderson J; Graham J; Pirmohamed M; Bernal W; Day CP; Aithal GP
    J Hepatol; 2010 Dec; 53(6):1049-53. PubMed ID: 20800921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.
    Nicoletti P; Aithal GP; Bjornsson ES; Andrade RJ; Sawle A; Arrese M; Barnhart HX; Bondon-Guitton E; Hayashi PH; Bessone F; Carvajal A; Cascorbi I; Cirulli ET; Chalasani N; Conforti A; Coulthard SA; Daly MJ; Day CP; Dillon JF; Fontana RJ; Grove JI; Hallberg P; Hernández N; Ibáñez L; Kullak-Ublick GA; Laitinen T; Larrey D; Lucena MI; Maitland-van der Zee AH; Martin JH; Molokhia M; Pirmohamed M; Powell EE; Qin S; Serrano J; Stephens C; Stolz A; Wadelius M; Watkins PB; Floratos A; Shen Y; Nelson MR; Urban TJ; Daly AK;
    Gastroenterology; 2017 Apr; 152(5):1078-1089. PubMed ID: 28043905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-Induced Liver Injury due to Flucloxacillin: Relevance of Multiple Human Leukocyte Antigen Alleles.
    Nicoletti P; Aithal GP; Chamberlain TC; Coulthard S; Alshabeeb M; Grove JI; Andrade RJ; Bjornsson E; Dillon JF; Hallberg P; Lucena MI; Maitland-van der Zee AH; Martin JH; Molokhia M; Pirmohamed M; Wadelius M; Shen Y; Nelson MR; Daly AK;
    Clin Pharmacol Ther; 2019 Jul; 106(1):245-253. PubMed ID: 30661239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-Wide Association Studies for Idiosyncratic Drug-Induced Hepatotoxicity: Looking Back-Looking Forward to Next-Generation Innovation.
    Petros Z; Makonnen E; Aklillu E
    OMICS; 2017 Mar; 21(3):123-131. PubMed ID: 28253087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of Oxidative Stress-Related Candidate Genes as Risk Factors for Drug-Induced Liver Injury due to Co-Amoxiclav.
    Alshabeeb MA; Aithal GP; Daly AK
    DNA Cell Biol; 2020 Mar; 39(3):349-354. PubMed ID: 31905014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic risk factors in the development of idiosyncratic drug-induced liver injury.
    Stephens C; Lucena MI; Andrade RJ
    Expert Opin Drug Metab Toxicol; 2021 Feb; 17(2):153-169. PubMed ID: 33222552
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic association studies in drug-induced liver injury.
    Daly AK; Day CP
    Semin Liver Dis; 2009 Nov; 29(4):400-11. PubMed ID: 19826974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver Injury.
    Cirulli ET; Nicoletti P; Abramson K; Andrade RJ; Bjornsson ES; Chalasani N; Fontana RJ; Hallberg P; Li YJ; Lucena MI; Long N; Molokhia M; Nelson MR; Odin JA; Pirmohamed M; Rafnar T; Serrano J; Stefánsson K; Stolz A; Daly AK; Aithal GP; Watkins PB; ;
    Gastroenterology; 2019 May; 156(6):1707-1716.e2. PubMed ID: 30664875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced liver injury: past, present and future.
    Daly AK
    Pharmacogenomics; 2010 May; 11(5):607-11. PubMed ID: 20415545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetic testing in idiosyncratic drug-induced liver injury: current role in clinical practice.
    Aithal GP
    Liver Int; 2015 Jul; 35(7):1801-8. PubMed ID: 25809692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs.
    Urban TJ; Shen Y; Stolz A; Chalasani N; Fontana RJ; Rochon J; Ge D; Shianna KV; Daly AK; Lucena MI; Nelson MR; Molokhia M; Aithal GP; Floratos A; Pe'er I; Serrano J; Bonkovsky H; Davern TJ; Lee WM; Navarro VJ; Talwalkar JA; Goldstein DB; Watkins PB; ; ; ; ;
    Pharmacogenet Genomics; 2012 Nov; 22(11):784-95. PubMed ID: 22968431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic basis of drug-induced liver injury: present and future.
    Urban TJ; Daly AK; Aithal GP
    Semin Liver Dis; 2014 May; 34(2):123-33. PubMed ID: 24879978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.
    Daly AK; Donaldson PT; Bhatnagar P; Shen Y; Pe'er I; Floratos A; Daly MJ; Goldstein DB; John S; Nelson MR; Graham J; Park BK; Dillon JF; Bernal W; Cordell HJ; Pirmohamed M; Aithal GP; Day CP; ;
    Nat Genet; 2009 Jul; 41(7):816-9. PubMed ID: 19483685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human leukocyte antigen genetic risk factors of drug-induced liver toxicology.
    Grove JI; Aithal GP
    Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):395-409. PubMed ID: 25491399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
    Kaniwa N; Saito Y
    J Hum Genet; 2013 Jun; 58(6):317-26. PubMed ID: 23635947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced liver injury.
    Grant LM; Rockey DC
    Curr Opin Gastroenterol; 2012 May; 28(3):198-202. PubMed ID: 22450893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chemical, genetic and immunological basis of idiosyncratic drug-induced liver injury.
    Tailor A; Faulkner L; Naisbitt DJ; Park BK
    Hum Exp Toxicol; 2015 Dec; 34(12):1310-7. PubMed ID: 26614821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives.
    Fontana RJ
    Gastroenterology; 2014 Apr; 146(4):914-28. PubMed ID: 24389305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.